CryoLife, Inc. (NYSE: CRY), a leading medical device company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of Hemosphere, Inc. Hemosphere developed and...
Within3, the market leader of private online community programs for life science and healthcare institutions, announced today its certification in Safe Harbor principles. This official acknowledgement from the U.S....
Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases,...
HYCOR Biomedical, Inc., a leading manufacturer of diagnostic products, and Roche today announced the signing of a global distribution agreement of KOVA® urinalysis products. As part of the agreement, Roche will distribute...
In the two-way mirror that often is a reflection of life or art, another trend is forming. The worlds of literature and Hollywood are colliding again, this time with a focus on cryonics, the science intended to reanimate...
AUSTIN, TX, May 15, 2012 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), an industry leader in providing pharmaceutical contract dosage development and clinical and commercial manufacturing, today announced its...
Polymer Group, Inc. (PGI) (the "Company") reported results of operations for the first quarter ended March 31, 2012.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance...
Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases,...
Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional...
Telik, Inc. (Nasdaq: TELK) today announced two publications in the Journal of Hematology & Oncology. The first is "Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with...
Stimatix GI Ltd., a leading developer of low-profile innovative solutions for colostomy management, announced today that it has completed its FDA registration and device listing for its AOS-C2000™ as part of its commercial...
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of those drugs and engaged in further drug...
Synchrogenix Information Strategies Inc., a regulatory writing company headquartered in Wilmington, Delaware, is pleased to announce the addition of a new office in Stockholm, Sweden, to be headed by Bengt Olsson.
The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into collaboration with Neurotune to investigate a potential treatment for ALS (aka Motor Neuron or Lou Gehrig's disease).
Argus Health Systems, Inc., a leading independent transparent pharmacy benefit administrator, will offer solutions on ways a pharmacy benefit manager can collaborate with a Part D plan sponsor to improve their CMS Five-Star...
Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented Bristol-Myers Squibb Company (NYSE: BMY) today announced...
BST-CarGel® treatment results in more repair cartilage of higher quality than microfracture, the current orthopaedic standard of care, with a similar safety profileThe BST-CarGel® trial met both co-primary endpoints by...
Stiefel, a GSK (NYSE: GSK) company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam, 0.1%. It is the only retinoid in a topical foam formulation for...
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™) announced completion of a pre-IND meeting with the Center for...
MARKHAM, ON, May 11, 2012 /PRNewswire/ - Cytochroma today announced positive clinical trial results for its lead product, CTAP101 Capsules. In a recently completed Phase 2b trial, CTAP101 Capsules effectively and safely...
Trinity College Dublin, the University of Dublin, (http://www.tcd.ie) Ireland's premier university's postgraduate courses, the MSc in Bioengineering and MSc in Neuroscience received Postgraduate Course of the Year...
Cell Therapeutics, Inc.("CTI") (Nasdaq and MTA: CTIC) today announced that it has received conditional marketing authorization from the European Commission ("EC") for Pixuvri® (pixantrone) as monotherapy for the treatment of...
What makes a Grand Challenge grand? Consider the complexities of curing breast cancer, purging greenhouse gases from the atmosphere, launching civilian spacecraft, or eradicating the devastating AIDS pandemic. These are the...
Simbionix USA Corporation, the world's leading provider of medical education and simulation training, is pleased to provide LAP Mentor customers with a new simulation-based Bariatric Curriculum, developed by educators...
World-class facility near Montreal offers applied R&D, training and specialty gamma processing
Reportlinker.com announces that a new market research report is available in its catalogue:
Mecca® Ointment, a century-old first aid family tradition now available across Canada
AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2012.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its first...
The Belgian biotechnology company, Cardio3--BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces that it has received...
China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), today reported higher financial...
GSI Group Inc. (NASDAQ: GSIG) (the "Company" or "GSI"), a global leader and supplier of laser-based solutions, laser scanning devices, and precision motion and optical technologies to global electronics, industrial,...
Brainybrawn, Inc. (Pink Sheets: BRNW) announced that its subsidiary Sanvi Infotech Pvt. Ltd (India) has launched Sanvi Medical College Information Management Solution (Sanvi MCIMS), a web based application for comprehensive...
Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2012. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of...
Content is the crown jewel for many companies supporting today's digitally connected customers, according to a survey by Data Conversion Laboratory (DCL), a leading provider of digital publishing services.
Span-America Medical Systems, Inc. (NASDAQ: SPAN) will provide an online, real-time webcast and rebroadcast of its conference call on Tuesday, May 8, 2012, covering results for the second quarter of fiscal 2012, which will...
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare today announced that Bayer's Japanese subsidiary, Bayer Yakuhin, Ltd. ("Bayer Yakuhin"), and Santen Pharmaceutical Co., Ltd.("Santen")entered into a...
The Partnership for Quality Home Healthcare today praised the U.S. Department of Veterans Affairs final rule eliminating copayments for tele-health services for Veterans receiving skilled home healthcare through the...
ProAssurance Corporation (NYSE:PRA) reports Operating Income of $48 million, or $1.56 per diluted share for the first quarter of 2012. Gross Premiums Written were $170 million, a 6% increase over the year-ago quarter. Book...
In Pennsylvania's latest effort to strengthen highway safety, 13 state troopers and seven municipal police officers have recently been trained as drug recognition experts, State Police Commissioner Frank Noonan announced...
Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases,...
Enters national licensing phase in 17 E.U. countriesMISSISSAUGA, ON, May 7, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical...
Today, U.S. regulators and representatives from national food production industries will meet to discuss "Improving Antimicrobial Use in Food Animal Production: Alternatives, Options and Incentives," in Washington, D.C....
UBM Canon is pleased to announce the return of the Medical Design & Manufacturing East Exposition and Conference (MD&M East). The four-day conference and three-day exposition will be held from Monday, May 21 through...
Kathleen Malaspina has been named Chief Innovation Officer and Vice President of Marketing for OrthoAccel Technologies. In this position, she will oversee marketing, clinical affairs, product innovations and international...
Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Bank of America Merrill Lynch 2012 Heath Care Conference on Wednesday, May...
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it will present scientific data from one oral and 16 poster presentations at the American Psychiatric Association...
Aflac, the number one provider of supplemental insurance in the United States and 11-time recipient of FORTUNE's World's Most Admired Companies designation, today helped unveil a new logo for the Aflac Cancer and...
TORONTO, May 4, 2012 /PRNewswire/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX:MSL, NASDAQ:MSLI] is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the...
A new, one-year, double-blind controlled clinical study shows that cacao-flavonoids and soy isoflavones can significantly improve biomarkers of CVD risk in postmenopausal women with type 2 diabetes[1]. The trial, conducted...
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012, at 11:20 a.m. PT.
Eli Lilly and Company (NYSE: LLY) today applauded law enforcement officials for their successful investigation and the recovery of more than $70 million in pharmaceuticals stolen from its United States distribution center...
Eli Lilly and Company (NYSE: LLY) will conduct a conference call for the investment community to provide a pipeline update on its Lilly Diabetes business on Monday, June 11, 2012. The call, which is being held in conjunction...
Okuma America Corporation has selected The Daniel Group to provide customer service research and strategies for cultivating customer loyalty.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the GLORIA™-AF Registry Program, the largest prospective observational study in non-valvular atrial fibrillation (NVAF) planned at this time. With a...
GSA South Carolina is pleased to announce that Turner Laboratories Inc. (Turner Labs) has been awarded a GSA Schedule 66 contract and is now certified to provide goods & services directly to the Federal government....
Dutch Medical Brands receives first European Class IIa Medical Device Status Instead of traditional treatment with antibiotics, bladder and urinary tract infections can be cured with cranberry capsules, without known side...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the...
CMC Biologics, a leading contract manufacturing organization (CMO) known and respected for its technical excellence in process development and cGMP manufacture, has been named a finalist for the 2012 Manufacturing Company...
Abbott (NYSE: ABT), one of India's largest health care companies, today announced plans to establish its first nutrition research and development center in the country in collaboration with Syngene, India's leading...
MISSISSAUGA, ON, May 2, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune...
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its quarter ended March 31, 2012.
Omnicell, Inc., (NASDAQ:OMCL) a leading provider of medication and supply management solutions to healthcare systems, today announced that it has signed an agreement to acquire MTS Medication Technologies, Inc., a worldwide...
Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the first quarter ended March 31, 2012.
Deadlines for lawsuits over side effects of the birth control drugs Yaz and Yasmin have been moved back another 90 days, the third time deadlines have been delayed this year. The extension by Chief Judge David R. Herndon, of...
Reportlinker.com announces that a new market research report is available in its catalogue:
TORONTO, May 2, 2012 /CNW/ - The Westaim Corporation (the "Company") (TSX: WED) announced today that it has entered into a definitive agreement (the "Agreement") with Intact Financial Corporation ("Intact") (TSX: IFC)...
Reportlinker.com announces that a new market research report is available in its catalogue:
CVS Caremark Corporation (NYSE: CVS) today announced revenues, operating profit and net income for the three months ended March 31, 2012.
QUEBEC CITY, May 1, 2012 /CNW Telbec/ - DiagnoCure, Inc. (TSX: CUR), a Quebec life sciences company that develops and commercializes high-value cancer diagnostic tests, issued a statement today commenting on the proposed...
Annai Systems Inc. announced today that it has granted to the University of California, Santa Cruz (UCSC) a multi-year license for the company's genomic network operating system (Annai-GNOS™). The Annai network engine...
pharmaCline's Diabecline® antibiotic ointment (SSPT® Tetracycline) received the Bronze Award for 2012 Best New Pharmaceutical Product at the 25th Annual Edison Awards in New York City. pharmaCline joined some of the...
Sproxil is using IBM (NYSE: IBM) technology to help the pharmaceutical industry reduce drug counterfeiting and allow consumers to verify the authenticity of prescriptions in seconds with their mobile phones.
Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised its option associated with the existing Pfenex...
ANSYS (NASDAQ: ANSS) subsidiary Apache Design, Inc. today introduced RedHawk™-3DX to meet the power, performance and price demands of low-power mobile, high-performance computing, consumer and automotive electronics. This...
June 24th deadline for applications to promote gender equity in academia and build capacity in developing world libraries The Elsevier Foundation is seeking new grant proposals for the 2012 New Scholars and Innovative...
KIRKLAND, QC, May 1, 2012 /CNW Telbec/ - Merck Canada supports Health Canada's initiative to ensure Canadians have quicker access to products that are switched from prescription to over-the-counter (OTC) medicines. On...
WINNIPEG, April 30, 2012 /PRNewswire/ - "We are delighted to announce that Mr. Hilmi Sunay, the former CEO of Rivosem (Istanbul, Turkey) has been working for Intelligent Hospital Systems as of April 1st, 2012. His knowledge...
Prem Reddy, M.D., FACC, FCCP, Chairman, President and CEO of Prime Healthcare Services, was honored by the Boys & Girls Clubs of Greater San Diego at the Club's 50th Annual Golden Achievement Awards Dinner for his...
Babson Executive Education, one of the world's top ranked executive education providers, is offering its flagship "BioPharma: Mastering the Business of Science" program in San Francisco from June 4-8, 2012. This is...
The DKMS 6th Annual Gala: Linked Against Blood Cancer, hosted by Katharina Harf, Chief Inspiration Officer of DKMS Americas, was held on Thursday night at Cipriani Wall Street to a sold out audience. The gala once again...
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of those drugs and engaged in further drug...
Results of a national study of nearly 76,000 laboratory tests for monitoring prescription drug use indicate that the majority of Americans tested misused their prescription drugs, including potentially addictive pain...
OTTAWA, April 27, 2012 /PRNewswire/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) reaffirms its strong support for Canada to conclude the Comprehensive Economic and Trade Agreement (CETA) with the...
Bangalore-based affordable medical technology and solutions company Forus Health Pvt. Ltd. (Forus) has successfully raised Series A funding of $5 million from two leading venture capital funds, Accel Partners and IDG...
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has...
(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Q1 2012 Change on a reported basis Change at constant exchange rates Net sales euro 8,511m +9.4% +7.0% Business net income(1) euro 2,442m +12.5% +8.4%...
Pharma IQ has just published the results of an industry-wide Solubility Report, conducted recently among 3,000 pharmaceutical solubility specialists. The results showed that improving API solubility is the greatest...
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Wednesday, May 2, to discuss the Company's...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and EUSA Pharma Inc. today announced that the companies have signed a definitive agreement under which Jazz Pharmaceuticals has agreed to acquire EUSA Pharma, a privately-held,...
UCB today announced interim results from the VITOBA™ (VImpaT® added to One Baseline AED) study, which showed that patients with less refractory partial-onset seizures treated with Vimpat® (lacosamide) C-V as add-on to...
Reportlinker.com announces that a new market research report is available in its catalogue:
IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today issued the following statement,
Online news publication in-PharmaTechnologist.com today launched a refocused website to deliver more targeted news in key biopharma manufacturing niches. Using the new, clearer design readers can customise...
Omthera Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, today announced positive top-line data from its EVOLVE (EpanoVa fOr Lowering Very High triglyceridEs) clinical study for Epanova™, the...
A dedicated journal for educational research and developments within management Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce publishing...
Internationally renowned supermodel Heidi Klum will join, today, the world's largest bone marrow donor center, DKMS, and leading global beauty company Coty Inc. illuminate the Empire State Building in red and...
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced record first-quarter results with revenue of $462.0 million, a 17 percent improvement over the prior-year period. Revenue was positively impacted 1 percent from foreign...
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2012.
All content © Copyright 2000-2011 WorldNow and KFDA. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
